Fenugreek (Trigonella foenum-graecum L. seed) is a food with traditional medicinal use in diabetes. Beneficial effects have been demonstrated in diabetic animals and both insulin-dependent and non-insulin-dependent diabetic subjects. Effects of a lipid extract A, crude ethanolic extract B, further sub-fractions of B (saponin-free C, saponin D and sapogenin E) and a gum fibre fraction F on intestinal sodium-dependent glucose uptake were investigated in vitro using rabbit intestinal brush border membrane vesicles. All fractions except A inhibited glucose-uptake at 0.33 and/or 3.3mg/mL (p < 0.001). Greatest inhibition was observed with fractions D and E. Diosgenin and trigonelline (compounds reported in fenugreek) also inhibited glucose-uptake (IC50 values approximately 3mg/ ml, equivalent to 8mM and 19mM respectively) but did not account for the activity of the crude extracts. Fenugreek extracts had no effect on basal levels of glycogen phosphorylase a (HGPa) activity in rat hepatocyte suspensions. However fractions C and E caused a marginal but statistically significant inhibition (18.9 and 15.1% respectively, p < 0.05) of glucagon induction of this enzyme suggesting a glucagon-antagonist effect. Diosgenin (1.65mg/ml; 4mM) inhibited glucagon-induced HGPa activity by 20% (p < 0.05), and was more effective than trigonelline (non significant inhibition of 9.4% at 1.65mg/ml, 10mM The anti-diabetic activity of fenugreek is primarily associated with the defatted fraction of the seeds, [8, 9, 1] and can be largely attributed to their saponin and high fibre content but not to the major alkaloid trigonelline. [5, 6, 111 Suggested mechanisms for fenugreek's anti-diabetic effects include delayed gastric emptying and interference with glucose absorption due to high fibre content, [5, 6, 11] inhibition of pancreatic c-amylase and intestinal disaccharidase enzymes, [2, 3] or the presence of an orally active principle capable of inducing hypoglycaemia [14, 15] or enhanced plasma insulin levels. [16, 17] The compound 4-hydroxyisoleucine, which represents up to 80% of free amino acids in fenugreek seeds, was found to possess insulin-secretagogue properties both in pancreatic islets in vitro and in rats and dogs in vivo. [18'19] In There is evidence from rat models that the expression of the sodium-dependent glucose transporter (SGLT-1) and a sodium-independent transporter GLUT-2 is raised in the diabetic state, thus increasing the likelihood of hyperglycaemia following a meal. [22'23'24] The major component of glucose transport in rat isolated enterocytes was found to be due to SGLT-1 [25] which can be blocked by the plant-derived glycoside phloridzin (phlorizin). [ 
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INTRODUCTION
Diabetes mellitus affects 3-5% of people living in Western countries and is a heterogeneous disorder with varying prevalence among different ethnic groups. [1] Based on the emerging relationship between hyperglycaemia and degree of glycaemic control on one side and the development of microvascular and macrovascular complications on the other, [2, 3] there is a growing interest in the inclusion of beneficial food substances in the diet to assist the control of glucose levels. . [4] In particular, anti-diabetic and hypocholesterolaemic effects have been demonstrated in diabetic animals and both insulin-dependent and non-insulin-dependent (Type I and Type II) diabetes mellitus. [4, 5, 6, 7] For example, [ 24 -hour urinary sugar excretion. [7] The anti-diabetic activity of fenugreek is primarily associated with the defatted fraction of the seeds, [8, 9, 1] and can be largely attributed to their saponin and high fibre content but not to the major alkaloid trigonelline. [5, 6, 111 Suggested mechanisms for fenugreek's anti-diabetic effects include delayed gastric emptying and interference with glucose absorption due to high fibre content, [5, 6, 11] inhibition of pancreatic c-amylase and intestinal disaccharidase enzymes, [2, 3] or the presence of an orally active principle capable of inducing hypoglycaemia [14, 15] or enhanced plasma insulin levels. [16, 17] The compound 4- hydroxyisoleucine, which represents up to 80% of free amino acids in fenugreek seeds, was found to possess insulin-secretagogue properties both in pancreatic islets in vitro and in rats and dogs in vivo. [18'19] In [20'21] and effects on liver glycogen degradation examined using isolated rat hepatocyte suspensions. A polysaccharide gum fibre fraction was tested in the intestinal model alone since intact polysaccharides would not be expected to reach the liver.
There is evidence from rat models that the expression of the sodium-dependent glucose transporter (SGLT-1) and a sodium-independent transporter GLUT-2 is raised in the diabetic state, thus increasing the likelihood of hyperglycaemia following a meal. [22'23'24] The major component of glucose transport in rat isolated enterocytes was found to be due to SGLT-1 [25] which can be blocked by the plant-derived glycoside phloridzin (phlorizin). [ Gum fibre was extracted according to a previously reported method. [5] Defatted seed powder (1 g) was extracted with acetic acid (5% aqueous, 100ml) by continual stirring at room temperature for 30 (Fig. 1) . Some incubations were continued to 5 minutes or 1 hour to ensure that equilibrium was obtained (Fig. 1) . Performance Indeed lower levels of GLUT-2 could be detected in rat BBMV even in the absence of glucose in the perfusate. [33] Nevertheless, it seems unlikely that GLUT-2 mediated transport occurs to any significant extent in the BBMV model reported in the present study since the uptake of labelled glucose into the vesicles was unaffected by the presence of up to 8mM fructose (data not presented), whereas fructose and glucose are known to exert mutual inhibition of uptake via GLUT-2 transporters. [341 With the exception of the petroleum ether extract (oil fraction, A) all the extracts significantly reduced (p < 0.0001) glucose uptake at the higher or both concentrations (Tab. I). Both layers derived from partitioning of the crude ethanol extract (B) inhibited uptake, indicating that both saponin (D) and non-saponin (C) constituents may be involved. There was no loss of activity on hydrolysing the saponins, indeed the greatest inhibition of glucose uptake was seen in the hydrolysed extract (E), believed to contain sapogenins (aglycones). On further fractionation of (E) by flash chromatography the main fraction G from this extract inhibited glucose uptake by 46%; whereas the other subfractions showed weaker inhibition (data not shown). The observed inhibition of glucose uptake in the aglycone fraction and its subfraction did not appear to be due to diosgenin or trigonelline, since no diosgenin or trigonelline could be detected in these fractions by TLC. Furthermore, diosgenin and trigonelline at 3.3mg/ml inhibited glucose uptake by only 45% and 55% as compared to the 81% inhibition by 3.3mg/ml of Extract (E). Of these two compounds diosgenin (8mM) was more potent than trigonelline (19.2mM 
